Walter C Darbonne

4PUBLICATIONS
38CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 11, 2026
Evaluation of a Tumor-Informed Molecular Residual Disease Assay in Early Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy, With or Without Atezolizumab.

|Apr 27, 2025
Improved overall survival in an anti-PD-L1 treated cohort of newly diagnosed glioblastoma patients is associated with distinct immune, mutation, and gut microbiome features: a single arm prospective phase I/II trial.

Shiao-Pei Weathers, Xiqi Li, Haifeng Zhu

|Jul 15, 2021
Efficacy, Safety, and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma.

Kanwal Raghav, Suyu Liu, Michael J Overman

|Jul 23, 2020
A Phase I Study of DLYE5953A, an Anti-LY6E Antibody Covalently Linked to Monomethyl Auristatin E, in Patients with Refractory Solid Tumors.

Sara M Tolaney, Khanh T Do, Joseph P Eder

Pageof 1

Frequent Collaborators

2 joint publications

Mark Knafl

2 joint publications

Dipen M Maru

1 joint publications

Montserrat Carrasco-Triguero

1 joint publications

S Renee Commerford